RNAC Cartesian Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$7,36
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$5,6052 haftanın en düşüğü
$11,0052 haftanın en yükseği
Piyasa Değeri (MRQ)
$221M
P/E (TTM)
-1.3
Hisse Başına Kâr (TTM)
$-5.84
Gelir (TTM)
$1M
rozetleriniz
52 Haftlık Aralık
$6–$11
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$34
P/E
-1.3
ROE
237.8%
Net Kâr Marjı
-10283.8%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
RNAC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$7.36
Piyasa Değeri (MRQ)
$221M
P/E (TTM)
-1.3
Hisse Başına Kâr (TTM)
$-5.84
Gelir (TTM)
$1M
ROE (TTM)
237.8%
D/E Borç/Özsermaye (MRQ)
-0.4
52 Haftlık Aralık
$6–$11
RNAC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 05 Nisan 2024 | 1-for-30 | Ters |
Cartesian Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar75
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$3M2017-12-31 → 2025-12-31
Hisse Başına Kâr$-5.022019-12-31 → 2025-12-31
Serbest Nakit Akışı$-79M2017-12-31 → 2025-12-31
Net kar marjı-10283.8%2017-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | RNAC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.35Y ort. ≈-22.3 | ≈-22.3 | · | · | |
| F/S (TTM) | 149.75Y ort. ≈63.6 | ≈63.6 | 36.6 | Aşırı değerli | |
| F/D (MRQ) | -1.85Y ort. ≈-5.4 | ≈-5.4 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -2.85Y ort. ≈-59.9 | ≈-59.9 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -2.95Y ort. ≈-62.9 | ≈-62.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | RNAC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -10518.6%5Y ort. ≈-1389.8% | ≈-1389.8% | -734.7% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | -5127.1%5Y ort. ≈-1389.8% | ≈-1389.8% | -734.7% | Zayıf | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -4987.3%5Y ort. ≈-1518.0% | ≈-1518.0% | -1318.8% | Zayıf | |
| Net Kâr Marjı (TTM) | -10283.8%5Y ort. ≈-1417.6% | ≈-1417.6% | -1287.2% | Zayıf | |
| ROA (TTM) | -42.9%5Y ort. ≈-32.0% | ≈-32.0% | -30.8% | Zayıf | |
| ROE (TTM) | 237.8%5Y ort. ≈729.3% | ≈729.3% | -23.4% | En üst düzey | |
| ROIC | 106.1%5Y ort. ≈196.9% | ≈196.9% | 8.4% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | RNAC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | -0.4 | · | · | · | |
| Cari Oran (MRQ) | 7.55Y ort. ≈6.3 | ≈6.3 | 7.7 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 8.55Y ort. ≈5.9 | ≈5.9 | 6.5 | Aynı seviyede | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | -0.4 | · | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | RNAC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -92.8%5Y ort. ≈64.6% | ≈64.6% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -70.7%5Y ort. ≈-25.8% | ≈-25.8% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -30.0% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | RNAC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.2 | ≈0.2 | 0.0 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 2.85Y ort. ≈8.0 | ≈8.0 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$37.3K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-16.2%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 5, 2026 | $0.61 | $-0.89 | 168.9% |
| 31 Mart 2026 | May 7, 2026 | $-1.46 | $-0.90 | -62.0% |
| 31 Aralık 2025 | $-3.57 | $-0.87 | -310.2% | |
| 30 Eylül 2025 | $-1.38 | $-0.86 | -60.1% | |
| 30 Haziran 2025 | $0.50 | $-0.83 | 160.5% | |
| 31 Mart 2025 | $-0.68 | $-0.72 | 5.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $39M | $26M | $111M | $85M | $17M | $7M | $903.0K | · | $8M | $6M | |
| R&D Expense | $58M | $45M | $71M | $72M | $69M | $55M | $43M | $48M | · | $30M | $23M | |
| SG&A Expense | $31M | $30M | $40M | $24M | $21M | $19M | $16M | $18M | · | $13M | $8M | |
| Operating Expenses | $146M | $83M | $112M | $96M | $90M | $73M | $59M | $66M | · | $43M | $31M | |
| Operating Income | $-143M | $-44M | $-86M | $15M | $-5M | $-57M | $-52M | $-65M | · | $-35M | $-25M | |
| Interest Expense | · | · | $3M | $3M | $3M | $2M | $2M | $1M | · | $1M | $948.0K | |
| Interest Income | $7M | $7M | $5M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-2M | $606.0K | $691.0K | $330.0K | $15.0K | $89.0K | $-1M | $10.0K | · | $4.0K | $-26.0K | |
| Pretax Income | $-139M | $-77M | $-239M | $35M | $-10M | $-69M | $-55M | · | · | · | · | |
| Income Tax | $-9M | $287.0K | $-19M | $-609.0K | $16M | $0 | $0 | · | · | · | · | |
| Net Income | $-130M | $-77M | $-220M | $35M | $-26M | $-69M | $-55M | $-65M | · | $-36M | $-25M | |
| EPS (Basic) | $-5.02 | $-4.48 | $-49.76 | $0.24 | $-0.22 | $-0.68 | $-1.22 | · | · | · | · | |
| EPS (Diluted) | $-5.02 | $-4.49 | $-49.76 | $0.10 | $-0.22 | $-0.68 | $-1.22 | · | · | · | · | |
| Shares (Basic) | 25,973,329 | 17,276,822 | 5,170,319 | 144,758,555 | 114,328,798 | 101,202,176 | 45,548,511 | · | · | · | · | |
| Shares (Diluted) | 25,973,329 | 17,357,943 | 5,170,319 | 145,874,889 | 114,328,798 | 101,202,176 | 45,548,511 | · | · | · | · | |
| EBITDA | $-143M | $-44M | $-86M | $15M | · | $-57M | $-52M | $-65M | · | $-35M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $213M | $77M | $106M | $114M | $139M | $90M | $37M | · | $59M | $32M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $26M | $25M | $4M | |
| Receivables | $1M | $872.0K | $6M | $7M | $10M | $7M | $5M | $0 | $63.0K | $215.0K | $824.0K | |
| Prepaid Expense | $3M | $3M | $5M | $4M | $6M | $5M | $1M | $5M | $2M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | $80.0K | · | · | · | |
| Current Assets | $129M | $217M | $91M | $148M | $144M | $151M | $97M | $42M | $99M | $87M | $39M | |
| PP&E (Net) | $12M | $10M | $2M | $3M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $17M | $12M | $8M | $8M | $7M | $6M | $6M | $7M | · | $6M | $5M | |
| Accum. Depreciation | $5M | $2M | $6M | $5M | $5M | $4M | $5M | $5M | · | $4M | $3M | |
| Goodwill | $48M | $48M | $48M | $0 | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | $518.0K | $0 | · | · | · | · | · | · | $122.0K | $2M | |
| Total Assets | $296M | $435M | $305M | $166M | $160M | $165M | $100M | $44M | $101M | $89M | $43M | |
| Accounts Payable | $1M | $288.0K | $3M | $316.0K | $224.0K | $443.0K | $500.0K | $1M | $2M | $4M | $2M | |
| Accrued Liabilities | $9M | $12M | $15M | $14M | $11M | $8M | $13M | $12M | $9M | $4M | $3M | |
| Current Liabilities | $15M | $23M | $68M | $25M | $72M | $82M | $35M | $35M | $11M | $14M | $7M | |
| Capital Leases | $9M | $11M | $9M | $10M | $9M | $10M | $0 | · | · | · | · | |
| Deferred Tax | $7M | $16M | $16M | $0 | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | $938.0K | $1M | $0 | $290.0K | |
| Total Liabilities | $423M | $442M | $445M | $72M | $137M | $183M | $91M | $50M | $47M | $34M | $22M | |
| Common Stock | $3.0K | $3.0K | $1.0K | $15.0K | $12.0K | $11.0K | $9.0K | $3.0K | $3.0K | $1.0K | $0 | |
| Paid-in Capital | $701M | $690M | $179M | $493M | $457M | $391M | $349M | $280M | $273M | $211M | $1.0K | |
| Retained Earnings | $-822M | $-692M | $-615M | $-395M | $-430M | $-405M | $-336M | $-280M | $-215M | $-152M | $-112M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-4M | $-5M | $-5M | |
| Stockholders' Equity | $-126M | $-7M | $-440M | $94M | $23M | $-18M | $8M | $-5M | $54M | $55M | $-116M | |
| Liabilities + Equity | $296M | $435M | $305M | $166M | $160M | $165M | $100M | $44M | $101M | $89M | $43M | |
| Shares Outstanding | 26,011,106 | 25,767,369 | 5,397,597 | 5,101,459 | 123,622,965 | 108,071,249 | 86,325,547 | 22,471,776 | · | 18,438,742 | 2,173,399 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $23M | $11M | $8M | $5M | $5M | $6M | · | · | · | |
| Deferred Tax | $-9M | $287.0K | $-19M | $0 | $0 | · | · | $0 | · | · | · | |
| Restructuring | $0 | $798.0K | $6M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-74M | $-24M | $-51M | $-32M | $-60M | $35M | $-51M | $-59M | · | $-20M | $-22M | |
| CapEx | $5M | $9M | $206.0K | $1M | $1M | $815.0K | $47.0K | $884.0K | · | $586.0K | $1M | |
| Investing Cash Flow | $-5M | $-9M | $35M | $-15M | $-17M | $-741.0K | $229.0K | $25M | · | $-22M | $-5M | |
| Debt Issued | · | · | · | $0 | $0 | $25M | $0 | $0 | · | · | · | |
| Net Debt Issued | · | $0 | $-27M | $0 | · | $5M | $-3M | $0 | · | $0 | · | |
| Stock Issued | · | · | · | $2M | $52M | $2M | $31M | $0 | · | $3M | $0 | |
| Net Stock Activity | · | · | · | $2M | · | · | $31M | $0 | · | $3M | · | |
| Financing Cash Flow | $-8M | $168M | $-13M | $39M | $53M | $14M | $105M | $697.0K | · | $68M | $44M | |
| Net Change in Cash | $-87M | $136M | $-30M | $-7M | $-25M | $49M | $54M | $-33M | · | $26M | $16M | |
| Free Cash Flow | $-79M | $-33M | $-51M | $-33M | · | $34M | $-51M | $-60M | · | $-20M | · | |
| Levered FCF | · | · | $-54M | $-36M | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5127.1% | -112.8% | -332.3% | 13.1% | · | -342.4% | -785.6% | -7200.7% | · | -428.9% | · | |
| Net Margin | -4658.6% | -199.0% | -844.9% | 31.9% | · | -415.0% | -829.0% | -7235.4% | · | -448.0% | · | |
| Pretax Margin | -4987.3% | -198.2% | -918.0% | 31.4% | · | · | · | · | · | · | · | |
| EBITDA Margin | -5127.1% | -112.8% | -332.3% | 13.1% | · | -342.4% | -785.6% | -7200.7% | · | -428.9% | · | |
| ROA | -35.6% | -20.9% | -93.3% | 21.7% | · | -52.0% | -76.8% | · | · | -54.8% | · | |
| ROE | 202.4% | 2559.5% | 115.7% | 39.6% | · | 542.6% | -3179.2% | · | · | 117.7% | · | |
| ROIC | 106.1% | 647.8% | 18.1% | 15.8% | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.7 | 9.4 | 1.3 | 5.9 | · | 1.9 | 2.8 | · | · | 6.3 | · | |
| Quick Ratio | 8.5 | 9.3 | 1.2 | 4.5 | · | 1.8 | 2.7 | · | · | 6.2 | · | |
| Interest Coverage | · | · | -30.5 | 4.8 | · | -36.5 | -34.5 | -43.5 | · | -27.7 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.7 | · | 0.1 | 0.1 | · | · | 0.1 | · | |
| Receivables Turnover | 2.8 | 11.5 | 4.2 | 13.4 | · | 2.7 | 2.7 | · | · | 15.6 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.85 | $-0.26 | $-2.72 | $0.61 | · | $-0.17 | $0.10 | · | · | $2.98 | · | |
| Revenue / Share | $0.11 | $2.24 | $0.17 | $0.76 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.85 | $-1.36 | $-0.33 | $-0.22 | · | · | · | · | · | · | · | |
| Cash / Share | $4.81 | $8.25 | $0.47 | $0.70 | · | $1.28 | $1.04 | · | · | $3.18 | · | |
| EPS (TTM) | $-5.02 | $-4.49 | $-49.76 | $0.10 | $-0.22 | $-0.68 | $-1.22 | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -92.8% | 49.6% | -76.5% | 30.2% | 412.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -70.7% | -22.9% | 16.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -30.0% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $39M | $26M | $111M | $85M | $17M | $7M | $903.0K | · | $8M | · | |
| Net Income TTM | $-130M | $-77M | $-220M | $35M | $-26M | $-69M | $-55M | $-65M | · | $-36M | · | |
| Market Cap | $188M | $461M | $3.35B | $5.19B | · | $9.82B | $6.16B | · | · | $9.49B | · | |
| P/E | -1.4 | -4.0 | -0.4 | 339.0 | -444.5 | -133.7 | -58.5 | · | · | · | · | |
| P/S | 67.1 | 11.9 | 128.7 | 46.8 | · | 591.9 | 923.1 | · | · | 1173.7 | · | |
| P/B | -1.5 | -67.8 | -7.6 | 55.3 | · | -545.6 | 734.0 | · | · | 172.6 | · | |
| P / Tangible Book | · | · | · | 55.3 | 536.8 | · | · | · | · | · | · | |
| P / Cash Flow | -2.5 | -19.5 | -65.4 | -164.0 | · | 281.6 | -119.8 | · | · | -482.0 | · | |
| P / FCF | -2.4 | -14.1 | -65.2 | -158.0 | · | 288.4 | -119.7 | · | · | -468.0 | · | |
| Earnings Yield | -69.6% | -25.1% | -240.7% | 0.29% | -0.22% | -0.75% | -1.7% | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $78.0K | $947.0K | $452.0K | $298.0K | $1M | $-759.0K | $387.0K | $33M | $6M | $8M | $7M | $5M | $6M | $17M | $21M | |
| R&D Expense | $20M | $19M | $15M | $14M | $15M | $15M | $11M | $11M | $13M | $10M | $22M | $13M | $18M | $19M | $19M | $17M | |
| SG&A Expense | $9M | $7M | $8M | $8M | $7M | $8M | $7M | $7M | $7M | $9M | $22M | $7M | $6M | $6M | $6M | $6M | |
| Operating Expenses | $29M | $27M | $80M | $22M | $22M | $23M | $26M | $18M | $20M | $19M | $45M | $20M | $24M | $24M | $25M | $22M | |
| Operating Income | $-29M | $-26M | $-79M | $-21M | $-22M | $-22M | $-27M | $-18M | $14M | $-13M | $-36M | $-13M | $-19M | $-18M | $-8M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | · | $1M | $752.0K | $808.0K | $807.0K | $802.0K | |
| Interest Income | $1M | $1M | · | · | $2M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $126.0K | $-3.0K | $-2M | $0 | $-5.0K | $0 | $-444.0K | $250.0K | $292.0K | $508.0K | $-62.0K | $253.0K | $245.0K | $255.0K | $175.0K | $1.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-197M | $-9M | · | · | $6M | $-8M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-288.0K | $-321.0K | |
| Net Income | $16M | $-39M | $-93M | $-36M | $16M | $-18M | $-10M | $-24M | $14M | $-57M | $-178M | $-9M | $-11M | $-22M | $6M | $-8M | |
| EPS (Basic) | $0.47 | $-1.46 | $-3.47 | $-1.38 | $0.51 | $-0.68 | $6.57 | $-1.13 | $0.58 | $-10.50 | $-41.55 | $-1.74 | $-2.23 | $-4.24 | $0.00 | $-0.05 | |
| EPS (Diluted) | $0.46 | $-1.46 | $-3.46 | $-1.38 | $0.50 | $-0.68 | $6.60 | $-1.13 | $0.54 | $-10.50 | $-41.55 | $-1.74 | $-2.23 | $-4.24 | $0.01 | $-0.05 | |
| Shares (Basic) | 29,467,130 | 26,855,158 | · | 26,002,892 | 25,980,262 | 25,902,650 | · | 21,471,408 | 16,723,479 | 5,414,020 | · | 5,160,150 | 5,114,747 | 5,111,518 | · | 152,849,992 | |
| Shares (Diluted) | 29,860,880 | 26,855,158 | · | 26,002,892 | 26,447,251 | 25,902,650 | · | 21,471,408 | 17,791,143 | 5,414,020 | · | 5,160,150 | 5,114,747 | 5,111,518 | · | 152,849,992 | |
| EBITDA | $-29M | $-26M | · | $-21M | $-22M | $-22M | · | $-18M | $14M | $-13M | · | $-13M | $-19M | $-18M | · | $-2M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $148M | $119M | $125M | $143M | $160M | $180M | $213M | $219M | $87M | $103M | $77M | $80M | $112M | $126M | $106M | $113M | |
| Receivables | $196.0K | $261.0K | $1M | $722.0K | $354.0K | $2M | $872.0K | $5M | $32M | $2M | $6M | $5M | $5M | $7M | $7M | $7M | |
| Prepaid Expense | $6M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $2M | $3M | $5M | $3M | $4M | $4M | $4M | $6M | |
| Current Assets | $154M | $122M | $129M | $147M | $163M | $185M | $217M | $229M | $125M | $111M | $91M | $90M | $123M | $138M | $148M | $160M | |
| PP&E (Net) | $11M | $12M | $12M | $12M | $12M | $10M | $10M | $10M | $7M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $17M | $17M | $17M | $17M | $16M | $13M | $12M | $17M | $13M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Accum. Depreciation | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | |
| Goodwill | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | $48M | · | · | · | $0 | · | |
| Other Non-current Assets | · | · | · | · | $6M | $6M | · | · | · | · | $0 | · | · | · | · | · | |
| Total Assets | $319M | $288M | $296M | $373M | $389M | $409M | $435M | $455M | $348M | $325M | $305M | $106M | $140M | $156M | $166M | $178M | |
| Accounts Payable | $1M | $2M | $1M | $2M | $454.0K | $2M | $288.0K | $517.0K | $3M | $3M | $3M | $375.0K | $267.0K | $1M | $316.0K | $214.0K | |
| Accrued Liabilities | $15M | $10M | $9M | $8M | $8M | $9M | $12M | $9M | $11M | $9M | $15M | $14M | $13M | $9M | $14M | $12M | |
| Current Liabilities | $21M | $16M | $15M | $14M | $12M | $15M | $23M | $21M | $26M | $37M | $68M | $20M | $29M | $27M | $25M | $24M | |
| Capital Leases | $7M | $8M | $9M | $9M | $10M | $10M | $11M | $12M | $12M | $8M | $9M | $9M | $9M | $10M | $10M | $11M | |
| Deferred Tax | $7M | $7M | $7M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | · | · | · | $0 | · | |
| Total Liabilities | $444M | $437M | $423M | $409M | $391M | $431M | $442M | $455M | $449M | $442M | $445M | $46M | $74M | $81M | $72M | $93M | |
| Total Debt | $53M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $1.0K | $1.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | |
| Paid-in Capital | $725M | $718M | $701M | $699M | $696M | $693M | $690M | $687M | $561M | $559M | $179M | $502M | $498M | $496M | $493M | $490M | |
| Retained Earnings | $-846M | $-862M | $-822M | $-730M | $-694M | $-710M | $-692M | $-682M | $-658M | $-671M | $-615M | $-437M | $-428M | $-417M | $-395M | $-401M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Stockholders' Equity | $-125M | $-148M | $-126M | $-36M | $-3M | $-22M | $-7M | $752.0K | $-101M | $-117M | $-440M | $60M | $65M | $75M | $94M | $85M | |
| Liabilities + Equity | $319M | $288M | $296M | $373M | $389M | $409M | $435M | $455M | $348M | $325M | $305M | $106M | $140M | $156M | $166M | $178M | |
| Shares Outstanding | 30,037,962 | 28,544,728 | 26,011,106 | 26,003,606 | 26,000,065 | 25,936,101 | 25,767,369 | 23,896,525 | 17,816,238 | 5,515,836 | 5,397,597 | 154,854,032 | 153,427,571 | 153,426,983 | 153,042,435 | 153,028,822 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $14M | $2M | $4M | $2M | $2M | $3M | |
| Restructuring | · | · | $0 | $0 | $0 | $0 | $21.0K | $-23.0K | $505.0K | $292.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-21M | $-22M | $-18M | $-16M | $-18M | $-23M | $-7M | $14M | $-14M | $-16M | $-23M | $-9M | $-10M | $-9M | $-12M | $4M | |
| CapEx | $272.0K | $27.0K | $492.0K | $1M | $3M | $1M | $705.0K | $6M | $2M | $602.0K | $64.0K | $0 | $12.0K | $130.0K | $211.0K | $436.0K | |
| Investing Cash Flow | $-272.0K | $-27.0K | $-492.0K | $-1M | $-3M | $-1M | $-354.0K | $-6M | $-2M | $-602.0K | $6M | $0 | $-12.0K | $28M | $5M | $-30M | |
| Stock Issued | $4M | $15M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $15M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $50M | $16M | $-52.0K | $-38.0K | $60.0K | $-8M | $783.0K | $124M | $120.0K | $43M | $14M | $-25M | $-3M | $149.0K | $0 | $612.0K | |
| Net Change in Cash | $29M | $-6M | $-18M | $-17M | $-20M | $-32M | $-7M | $132M | $-16M | $27M | $-3M | $-34M | $-13M | $19M | $-6M | $-25M | |
| Free Cash Flow | · | $-22M | · | · | · | $-24M | · | · | · | $-17M | · | · | · | $-9M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -33973.1% | · | -4660.6% | -7319.1% | -1989.9% | · | -4541.3% | 41.1% | -228.6% | · | -199.4% | -355.1% | -309.6% | · | -7.7% | |
| Net Margin | · | -50233.3% | · | -7942.9% | 5330.9% | -1610.0% | · | -6248.8% | 41.4% | -973.0% | · | -137.4% | -216.9% | -364.8% | · | -38.1% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -137.4% | · | · | · | -39.7% | |
| EBITDA Margin | · | -33973.1% | · | -4660.6% | -7319.1% | -1989.9% | · | -4541.3% | 41.1% | -228.6% | · | -199.4% | -355.1% | -309.6% | · | -7.7% | |
| ROA | 4.5% | -11.2% | · | -8.7% | 4.3% | -4.8% | · | -8.6% | 5.7% | -23.6% | · | -6.3% | -7.0% | -14.4% | · | -4.6% | |
| ROE | -24.7% | 46.1% | · | 204.6% | -30.6% | 25.6% | · | -79.2% | -76.8% | 269.2% | · | -12.4% | -14.7% | -33.2% | · | -23.8% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.8% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.5 | 7.7 | · | 10.7 | 13.3 | 12.3 | · | 10.7 | 4.8 | 3.0 | · | 4.5 | 4.2 | 5.2 | · | 6.7 | |
| Quick Ratio | 7.2 | 7.5 | · | 10.4 | 13.1 | 12.1 | · | 10.5 | 4.6 | 2.9 | · | 4.2 | 4.0 | 5.0 | · | 5.0 | |
| Debt / Equity | -0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | -0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -10.3 | -24.8 | -22.7 | · | -2.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 0.0 | 0.1 | · | 0.2 | 0.0 | 0.6 | · | 0.1 | 1.8 | 1.3 | · | 1.1 | 0.4 | 0.8 | · | 2.9 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.17 | $-5.19 | · | $-1.38 | $-0.10 | $-0.84 | · | $0.03 | $-5.69 | $-21.18 | · | $0.39 | $0.43 | $0.49 | · | $0.55 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.02 | $0.01 | $0.04 | · | $0.02 | $1.88 | $1.08 | · | $0.04 | $0.03 | $0.04 | · | $0.14 | |
| Cash Flow / Share | · | $-0.82 | · | · | · | $-0.89 | · | · | · | $-2.94 | · | · | · | $-0.06 | · | · | |
| Cash / Share | $4.91 | $4.16 | · | $5.51 | $6.17 | $6.96 | · | $9.17 | $4.90 | $18.75 | · | $0.51 | $0.73 | $0.82 | · | $0.74 | |
| EPS (TTM) | $-5.84 | $-5.80 | · | $5.04 | $5.29 | $5.33 | · | $-52.64 | $-53.25 | $-56.02 | · | $-8.20 | $-6.51 | $-4.22 | · | $0.25 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $2M | · | $1M | $1M | $34M | · | $48M | $54M | $26M | · | $35M | $49M | $83M | · | $124M | |
| Net Income TTM | $-152M | $-152M | · | $-48M | $-36M | $-38M | · | $-245M | $-230M | $-255M | · | $-36M | $-35M | $-15M | · | $42M | |
| Market Cap | $313M | $176M | · | $266M | $270M | $342M | · | $385M | $481M | $108M | · | $4.92B | $5.16B | $6.40B | · | $7.53B | |
| Enterprise Value | $218M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.8 | -1.1 | · | 2.0 | 2.0 | 2.5 | · | -0.3 | -0.5 | -0.3 | · | -3.9 | -5.2 | -9.9 | · | 196.8 | |
| P/S | 211.9 | 98.9 | · | 243.6 | 263.3 | 10.0 | · | 8.0 | 8.9 | 4.2 | · | 142.6 | 105.9 | 77.3 | · | 60.8 | |
| P/B | -2.5 | -1.2 | · | -7.4 | -106.9 | -15.7 | · | 512.2 | -4.7 | -0.9 | · | 81.6 | 78.8 | 85.8 | · | 88.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 81.6 | 78.8 | 85.8 | · | 88.7 | |
| P / Cash Flow | · | -7.9 | · | · | · | -14.8 | · | · | · | -6.8 | · | · | · | -729.9 | · | · | |
| EV / Revenue | 147.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -56.0% | -94.3% | · | 49.3% | 50.9% | 40.4% | · | -326.6% | -197.2% | -287.3% | · | -25.8% | -19.4% | -10.1% | · | 0.51% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $3M | $39M | $26M | $111M | $85M |
| Faaliyet Kâr Marjı % | -5127.1% | -112.8% | -332.3% | 13.1% | · |
| Net Gelir | $-130M | $-77M | $-220M | $35M | $-26M |
| Seyreltilmiş Hisse Başı Kâr | $-5.02 | $-4.49 | $-49.76 | $0.10 | $-0.22 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 8.7 | 9.4 | 1.3 | 5.9 | · |
| Cari Oran | 8.5 | 9.3 | 1.2 | 4.5 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-79M | $-33M | $-51M | $-33M | · |
Kurumsal Sahipler (13F) 101 dosya · $93.7M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
101
Tutulan Değer
$93.7M
Yeni pozisyonlar
27
Çıkan pozisyonlar
11
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 27 (-1 önceki Ç'ye göre) | 11 (-1 önceki Ç'ye göre) | 44 (+16 önceki Ç'ye göre) | 12 (-2 önceki Ç'ye göre) | +1.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Squarepoint Ops LLC | $23.493.130 | 2.254.619 | 25,08% | Hisse senetleri |
| BlackRock, Inc. | $8.536.469 | 819.239 | 9,11% | Hisse senetleri |
| 683 Capital Management, LLC | $6.773.001 | 650.000 | 7,23% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.791.676 | 555.823 | 6,18% | Hisse senetleri |
| VANGUARD GROUP INC | $3.902.253 | 541.228 | 4,17% | Hisse senetleri |
| FMR LLC | $3.839.030 | 368.429 | 4,10% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $3.715.412 | 356.525 | 3,97% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $3.714.267 | 356.456 | 3,96% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $3.229.023 | 309.887 | 3,45% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $3.087.373 | 296.293 | 3,30% | Hisse senetleri |
| STATE STREET CORP | $2.596.789 | 249.212 | 2,77% | Hisse senetleri |
| MARSHALL WACE, LLP | $2.427.018 | 232.919 | 2,59% | Hisse senetleri |
| UBS Group AG | $2.174.102 | 208.647 | 2,32% | Hisse senetleri |
| Privium Fund Management B.V. | $1.580.454 | 151.675 | 1,69% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.351.474 | 129.700 | 1,44% | Alım opsiyonu |
| NORTHERN TRUST CORP | $1.101.373 | 105.698 | 1,18% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $1.030.298 | 98.877 | 1,10% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $957.119 | 91.854 | 1,02% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $909.843 | 87.317 | 0,97% | Hisse senetleri |
| DIADEMA PARTNERS LP | $907.134 | 87.057 | 0,97% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $881.782 | 84.624 | 0,94% | Hisse senetleri |
| Walleye Capital LLC | $852.648 | 81.828 | 0,91% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $839.560 | 80.572 | 0,90% | Hisse senetleri |
| Jump Financial, LLC | $696.056 | 66.800 | 0,74% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $666.640 | 63.977 | 0,71% | Hisse senetleri |
| Nuveen, LLC | $661.191 | 63.454 | 0,71% | Hisse senetleri |
| CM Management, LLC | $625.200 | 60.000 | 0,67% | Hisse senetleri |
| Point72 Asset Management, L.P. | $454.590 | 43.627 | 0,49% | Hisse senetleri |
| Trexquant Investment LP | $427.699 | 41.046 | 0,46% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $338.650 | 32.500 | 0,36% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $335.191 | 32.168 | 0,36% | Hisse senetleri |
| Bank of New York Mellon Corp | $331.523 | 31.816 | 0,35% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $298.543 | 28.651 | 0,32% | Hisse senetleri |
| Atlatl Advisers LLC | $297.064 | 28.509 | 0,32% | Hisse senetleri |
| IEQ CAPITAL, LLC | $264.835 | 25.416 | 0,28% | Hisse senetleri |
| TWIN FOCUS CAPITAL PARTNERS, LLC | $260.500 | 25.000 | 0,28% | Hisse senetleri |
| Persistent Asset Partners Ltd | $231.230 | 22.191 | 0,25% | Hisse senetleri |
| Miller Financial Services LLC | $230.730 | 22.143 | 0,25% | Hisse senetleri |
| Erste Asset Management GmbH | $227.176 | 23.566 | 0,24% | Hisse senetleri |
| Ikarian Capital, LLC | $216.809 | 20.807 | 0,23% | Hisse senetleri |
| Invesco Ltd. | $215.559 | 20.687 | 0,23% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $212.568 | 20.400 | 0,23% | Satım opsiyonu |
| RENAISSANCE TECHNOLOGIES LLC | $211.526 | 20.300 | 0,23% | Hisse senetleri |
| XTX Topco Ltd | $202.096 | 19.395 | 0,22% | Hisse senetleri |
| Brevan Howard Capital Management LP | $201.783 | 19.365 | 0,22% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $178.866 | 24.808 | 0,19% | Hisse senetleri |
| Cerity Partners LLC | $175.557 | 16.848 | 0,19% | Hisse senetleri |
| Mariner, LLC | $154.334 | 14.813 | 0,16% | Hisse senetleri |
| JANE STREET GROUP, LLC | $141.712 | 13.600 | 0,15% | Alım opsiyonu |
| RHUMBLINE ADVISERS | $140.589 | 13.493 | 0,15% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Murat Kalayoglu, Seven One Eight Three Four Irrevocable Trust, Elizabeth Hoge, Sinan Kalayoglu ×4 başvurular | 02 Nisan 2026 | 19,90% | Değişiklik | · | SEC |
| Timothy A. Springer, TAS Partners LLC, Chafen Lu ×20 başvurular | 15 Ocak 2025 | 36,90% | Değişiklik | · | SEC |
| Michael Singer, Thirsty Brook 2010 Irrevocable Trust, Singer Asefzadeh Family Holding Trust, Bakezilla 2019 Irrevocable Trust, Baharak Asefzadeh, Barbara P. Martin ×2 başvurular | 10 Nisan 2024 | · | İlk başvuru | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire, Amir Nashat ×5 başvurular | 12 Şubat 2020 | · | İlk başvuru | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×6 başvurular | 05 Şubat 2020 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 39 içeriden öğrenenler · 21 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Carsten Brunn | President and CEO | 06 Ocak 2026 S | 323.530 | 0 | 1 | $-162.084 |
| Werner Cautreels | President and CEO | 13 Kasım 2017 P | 321.203 | 0 | 0 | $0 |
| Blaine Davis | Chief Financial Officer | 06 Ocak 2026 S | 121.220 | 0 | 1 | $-72.231 |
| Kevin Tan | Chief Financial Officer | 03 Ocak 2022 A | 77.000 | 0 | 0 | $0 |
| Bradford D. Dahms | Chief Financial Officer | 04 Ocak 2021 A | 38.000 | 0 | 0 | $0 |
| John Harold Leaman | CFO, Treas. & Hd Corp Strategy | 15 Haziran 2018 A | · | 0 | 0 | $0 |
| David Siewers | CFO and Treasurer | 20 Eylül 2017 M | 0 | 0 | 0 | $0 |
| Milos Miljkovic | Chief Medical Officer | 06 Ocak 2026 S | 58.820 | 0 | 1 | $-24.368 |
| June Ann Seymour | Chief Accounting Officer | 02 Ocak 2026 A | 6.500 | 0 | 0 | $0 |
| Emily English | Chief Operations Officer | 02 Ocak 2026 A | 94.226 | 0 | 0 | $0 |
| Christopher M Jewell | Chief Scientific Officer | 10 Ocak 2025 M | 62.490 | 0 | 0 | $0 |
| Metin Kurtoglu | Chief Technology Officer | 06 Ocak 2025 S | 62.258 | 0 | 0 | $0 |
| Peter G Traber | Chief Medical Officer | 25 Eylül 2023 S | 451.826 | 0 | 0 | $0 |
| Takashi Kei Kishimoto | Chief Scientific Officer | 31 Mayıs 2023 G | 225.316 | 0 | 0 | $0 |
| Lloyd P. Johnston | Chief Operations Officer | 05 Ocak 2023 S | 265.515 | 0 | 0 | $0 |
| Alison D. Schecter | Chief Medical Officer | 02 Ocak 2020 A | · | 0 | 0 | $0 |
| Stephen Smolinski | Chief Commercial Officer | 02 Ocak 2020 A | 13.812 | 0 | 0 | $0 |
| Elona Kogan Esq. | General Counsel | 02 Ocak 2020 A | 182.872 | 0 | 0 | $0 |
| David Abraham | GC, CCO & Corporate Secretary | 15 Haziran 2018 A | 5.405 | 0 | 0 | $0 |
| Earl Sands | Chief Medical Officer | 17 Kasım 2017 P | 7.500 | 0 | 0 | $0 |
| Peter Keller | Chief Business Officer | 07 Temmuz 2017 A | 405 | 0 | 0 | $0 |
| Michael Singer | Yönetim kurulu üyesi | 13 Mart 2026 G | 49.578 | 0 | 0 | $0 |
| Kemal Malik | Yönetim kurulu üyesi | 02 Ocak 2026 A | 11.133 | 0 | 0 | $0 |
| Nishan M Desilva | Yönetim kurulu üyesi | 02 Ocak 2026 A | 11.366 | 0 | 0 | $0 |
| Timothy C Barabe | Yönetim kurulu üyesi | 02 Ocak 2026 A | 56.966 | 1 | 0 | $205.800 |
| ZENNER PATRICK J | Yönetim kurulu üyesi | 02 Ocak 2026 A | 12.974 | 0 | 0 | $0 |
| Timothy A. Springer | Yönetim kurulu üyesi | 02 Ocak 2026 A | 8.646.285 | 0 | 0 | $0 |
| Adrian Ion Bot | Yönetim kurulu üyesi | 16 Aralık 2025 A | 5.800 | 0 | 0 | $0 |
| COX CARRIE SMITH | Yönetim kurulu üyesi | 02 Ocak 2025 A | 15.629 | 0 | 0 | $0 |
| Aymeric Sallin | Yönetim kurulu üyesi | 02 Ocak 2024 A | 178.000 | 0 | 0 | $0 |
| Scott Dunseth Myers | Yönetim kurulu üyesi | 13 Kasım 2023 D | 80.845 | 0 | 0 | $0 |
| ANDO GORAN | Yönetim kurulu üyesi | 02 Ocak 2023 A | · | 0 | 0 | $0 |
| Omid Farokhzad | Yönetim kurulu üyesi | 14 Haziran 2019 A | 83.333 | 0 | 0 | $0 |
| Amir Nashat | Yönetim kurulu üyesi | 14 Haziran 2019 A | 2.676.234 | 0 | 0 | $0 |
| Peter Barton Hutt | Yönetim kurulu üyesi | 15 Haziran 2018 A | · | 0 | 0 | $0 |
| Edwin M Kania JR | Yönetim kurulu üyesi | 16 Mayıs 2017 S | 560.067 | 0 | 0 | $0 |
| GORDON CARL L | Yönetim kurulu üyesi | 27 Haziran 2016 C | 1.825.415 | 0 | 0 | $0 |
| Murat Kalayoglu | 10% sahip | 02 Nisan 2026 M | 5.313.261 | 0 | 0 | $0 |
| RUSNANO | 10% sahip | 27 Haziran 2016 C | 1.476.177 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 13 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| JSML · Janus Detroit Street Trust | 0,42% | 195.163 NS | 31 Temmuz 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,40% | 12.916 SH | 01 Ekim 2026 | Günlük |
| IWC · iShares Trust | 0,03% | 43.834 SH | 11 Eylül 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 10.285 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,00% | 332.444 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,00% | 6.280 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 17.053 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 169.730 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 376.309 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 74.975 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.441 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 616 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 94.295 SH | 11 Eylül 2026 | Günlük |
RNAC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 14 analist
AL
Medyan hedef
$38.50
+423,1%
5 35,7%
Güçlü Al
8 57,1%
Al
1 7,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
6 analist · 2026-09-28Ortalama hedef $33.67 +357,4%
← Tüm hedeflerin altında
Mevcut fiyat $7.36
Düşük$16.00
Ortalama$33.67
Yüksek$44.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026